WJ47156

· Shanghai Junshi Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WJ47156, covering 2025-02-21 to 2025-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors [Phase 1]